Preview Mode Links will not work in preview mode

Apr 24, 2021

Featuring slide presentations and related discussion from Drs Tanya B Dorff, Fred Saad, A Oliver Sartor and Matthew R Smith, including the following topics:

  • Therapeutic Options for Patients with Metastatic Hormone-Sensitive Prostate Cancer — Fred Saad, MD (0:00)
  • Management of Nonmetastatic Castration-Resistant Prostate Cancer (CRPC) — Tanya B Dorff, MD (28:06)
  • Integration of PARP Inhibitors into the Management of Metastatic CRPC — Matthew R Smith, MD, PhD (55:33)
  • Current and Future Management Paradigms for Metastatic CRPC — A Oliver Sartor, MD (1:31:56)

CME information and select publications